June 29, 2006
STATEMENT
NIAID Trials of Adult Male Circumcision to Continue
On June 27 and 28, the Data and Safety Monitoring Board (DSMB) of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS), met to review interim data from two NIAID-sponsored clinical trials of adult male circumcision to prevent HIV acquisition. The trials are being conducted in Kenya and Uganda. The DSMB analyzed the available data and recommended an additional interim analysis within the next year. At this time, there are not enough efficacy data to justify an early end to either trial. The DSMB did not identify any significant safety concerns in either trial. The trial in Uganda is scheduled to end in July 2007; the trial in Kenya is scheduled to end in September 2007.
For additional information about the trials, see Q&A: Adult Male Circumcision Trials in Kenya and Uganda
Media inquires can be directed to the NIAID OCPL media group at 301-402-1663, niaidnews@niaid.nih.gov.
NIAID is a component of the National Institutes of Health. NIAID supports basic and applied research to prevent, diagnose and treat infectious diseases such as HIV/AIDS and other sexually transmitted infections, influenza, tuberculosis, malaria and illness from potential agents of bioterrorism. NIAID also supports research on basic immunology, transplantation and immune-related disorders, including autoimmune diseases, asthma and allergies.
The National Institutes of Health (NIH)—The Nation's Medical Research Agency—includes 27 Institutes and Centers and is a component of the U. S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical and translational medical research, and it investigates the causes, treatments and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov
###
back to top